NOSPECS improvement (decrease) by 2 classes or more · thyroid‐associated ophthalmopathy
It is very uncertain whether summary of findings table ‐ Rituximab changes NOSPECS improvement (decrease) by 2 or more classes compared with intravenous methylprednisolone (very low certainty).
1 finding from 1 review
Proptosis improvement (decrease) by 2 mm or more · thyroid‐associated ophthalmopathy
It is very uncertain whether summary of findings table ‐ Rituximab changes proptosis improvement (decrease) by 2 mm or more compared with intravenous methylprednisolone (very low certainty).
1 finding from 1 review
Palpebral aperture improvement (decrease) by 3 mm or more · thyroid‐associated ophthalmopathy
It is very uncertain whether summary of findings table ‐ Rituximab changes palpebral aperture improvement (decrease) by 3 mm or more compared with intravenous methylprednisolone (very low certainty).
1 finding from 1 review
Motility improvement (increase) by 1 class or more · thyroid‐associated ophthalmopathy
It is very uncertain whether summary of findings table ‐ Rituximab changes motility improvement (increase) by 1 class or more compared with intravenous methylprednisolone (very low certainty).
1 finding from 1 review
CAS improvement (decrease) by 2 or more points · thyroid‐associated ophthalmopathy
It is very uncertain whether summary of findings table ‐ Rituximab changes CAS improvement (decrease) by 2 or more points compared with placebo (very low certainty).
1 finding from 1 review
NOSPECS improvement (decrease) by 2 classes or more · thyroid‐associated ophthalmopathy
It is very uncertain whether summary of findings table ‐ Rituximab changes NOSPECS improvement (decrease) by 2 classes or more compared with placebo (very low certainty).
1 finding from 1 review
Systolic blood pressure. Dose 1500 mg a day or more (range of · People who may be at risk for primary hypertension
1 finding from 1 review
Number of people who experienced 1 or more admissions to a nursing care facility · older people living in the community with frailty
1 finding from 1 review
Change in visual loss associated with PSR: visual loss is defined by the deterioration of visual acuity of 3 lines or more with the Snellen chart · children and adults with SCD and PSR
1 finding from 1 review
Measurable change in stereopsis after 8 (± 2) weeks and 16 (± 2) weeks of intervention 'Real change' in stereopsis is defined as a change in stereoacuity of two or more octaves. · 5‐ to 8‐year‐old children with amblyopia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of people who experienced one or more falls · people with Parkinson's disease
It is very uncertain whether summary of findings for education changes number of people who experienced one or more falls compared with control (very low certainty).
1 finding from 1 review
Number of people sustaining one or more fall‐related fractures · people with Parkinson's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of people who experienced one or more falls · people with Parkinson's disease
Summary of findings for exercise showed no clear difference in number of people who experienced one or more falls compared with control (moderate certainty).
1 finding from 1 review
Number of people who experienced one or more falls · people with Parkinson's disease
Summary of findings for exercise plus education showed no clear difference in number of people who experienced one or more falls compared with control (low certainty).
1 finding from 1 review
Number of people sustaining one or more fall‐related fractures · people with Parkinson's disease
It is very uncertain whether summary of findings for exercise plus education changes number of people sustaining one or more fall‐related fractures compared with control (very low certainty).
1 finding from 1 review
Number of people sustaining one or more fall‐related fractures · people with Parkinson's disease
It is very uncertain whether summary of findings for exercise changes number of people sustaining one or more fall‐related fractures compared with control (very low certainty).
1 finding from 1 review
Number of people who experienced one or more falls · people with Parkinson's disease
1 finding from 1 review
Number of people sustaining one or more fall‐related fractures · people with Parkinson's disease
1 finding from 1 review
Asthma exacerbations · people with asthma
Digital adherence interventions may leads to lower asthma exacerbations ‐ Number of people with one or more exacerbations compared with usual care (low certainty).
1 finding from 1 review
Clinician‐reported signs of eczema: number of participants with one or more relapses (16‐20 weeks) · children and adults with mild to severe eczema
Weekend therapy probably leads to lower clinician‐reported signs of eczema: number of participants with one… compared with no topical corticosteroid (moderate certainty).
1 finding from 1 review